BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine

ATLANTA, May 20 /PRNewswire/ — Germany will present itself as one of the
world’s leading regenerative medicine research locations at this year’s BIO
International Convention. Under the “Breakthroughs in Regenerative Medicines
in Germany” banner, German experts will provide invaluable insight into the
latest research results in the area of regenerative medicine in Germany. The
German research landscape and the regulatory framework conditions will be
introduced in a presentation in which the most recent industry successes will
also be demonstrated.

Dr. Manfred Rudiger, CEO of Frankfurt-based t2cure GmbH, and Prof. Dr.

Georg N. Duda, Vice Director of the Berlin-Brandenburg Center for
Regenerative Therapies (BCRT), will also speak at the Germany Trade &
Invest-organized event. Both are experts and active partners in the German
research and enterprise landscape in the area of regenerative medicine.

Regenerative medicine offers rich and varied potential at a time when
western social welfare states are confronted with the problem of rapidly
aging populations and overloaded health systems. It is generally expected
that not only should the quality of life of the patient be improved by
regenerative treatments, but also that health systems be sustainably
disburdened by eliminating protracted aftercare and complications.

Germany takes center-stage in the presentation as an innovative location
with favorable research conditions. In this respect, highlighted in
particular is the excellent cross-linking among German universities as well
as with other research and development institutions. In combination with the
strong political will to actively promote promising regenerative medicine
projects, the high quality of existing research networks provide a strong
argument for investment in Germany.

As well as highlighting German initiative-led successes in regenerative
medicine to date, the event at the Georgia World Congress Center in Atlanta
will also illustrate future growth potential within the sector in Germany.

The annual BIO International Convention is the largest global event for
the biotechnology industry. It takes place at changing locations within the
USA and attracts participating exhibitors from around 50 countries. This
year’s BIO takes place until Thursday, May 21, 2009, at the Georgia World
Congress Centers in Atlanta. The German Pavilion is located in Building B,
Hall B2.

Germany Trade & Invest is the foreign trade and inward investment
promotion agency of the Federal Republic of Germany. The organization advises
and supports foreign companies seeking to expand into the German market and
assists companies established in Germany looking to enter foreign markets.

    http://www.gtai.com

    Media Contact:
    Eva Henkel
    Email: eva.henkel@gtai.com
    Phone: +49(0)30-200099-173
    Fax:   +49(0)30-200099-111

SOURCE Germany Trade and Invest